
Highlights
Oct 2021
Jadeite Medicines Inc. (“Jadeite”), a biopharmaceutical company that is backed by Singapore’s CBC Group (“CBC”) and committed to addressing critical unmet medical needs for patients in Japan, today entered into an exclusive licensing agreement with Albireo Pharma, Inc. (Nasdaq: ALBO) for the development and commercialization of odevixibat in Japan for progressive familial intrahepatic cholestasis (PFIC), Alagille syndrome (ALGS) and biliary atresia.
Oct 2021
Sep 2021
Jun 2021
May 2021
Apr 2021
Apr 2021
Apr 2021
Apr 2021
Apr 2021
Apr 2021
Apr 2021
Apr 2021
Jun 2020
Jun 2020
Apr 2020
Apr 2020
Apr 2020
Mar 2020
Mar 2020
Feb 2020
Jan 2020
Jan 2020
Dec 2019
Dec 2019
Dec 2019
Nov 2019
Oct 2019
Sep 2019
Jun 2019
May 2019
May 2019
Apr 2019
Mar 2019
Apr 2018